L-Ornithine + L-Aspartate

Indications

L-Ornithine + L-Aspartate is used for: Treatment of hyperammonemia due to acute or chronic liver disease, e.g., liver cirrhosis, fatty liver and hepatitis. Treatment of precoma of hepatic encephalopathy.

Adult Dose

Oral 1-2 tab three times a day

Child Dose

Renal Dose

Administration

Contra Indications

Hypersensitivity to L-ornithine-L-aspartate. Severely impaired renal function (renal insufficiency).

Precautions

There are no clinical data available on the use of L-ornithine-L-aspartate in pregnancy. It is not known whether L-ornithine-L-aspartate secreted into breast milk. Therefore, administration of L-ornithine-L-aspartate should be avoided during lactation. Depending on the underlying disease, the ability to drive and operate machines may also be impaired on treatment with L-ornithine-L-aspartate.

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of L-Ornithine + L-Aspartate : Nausea, vomiting, sensation of heat and palpitation. Generally, these symptoms are transient and do not necessitate discontinuation of treatment with L-ornithine-L-aspartate. The symptoms disappear on reduction of the dose or infusion rate.

Mechanism of Action